<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> subjects was investigated before and 6 months after insulin administration in 43 type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients (28 females and 15 males) </plain></SENT>
<SENT sid="1" pm="."><plain>Their age was 56.1+/-8.6 years, <z:mp ids='MP_0002055'>diabetes</z:mp> duration 11.7+/-6.8 years, BMI 29.5+/-5.3 kg/m2 </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were on maximal dosage of oral hypoglycaemic agents and had poor metabolic control (HbA1c 11.2+/-1.6%) </plain></SENT>
<SENT sid="3" pm="."><plain>Insulin sensitivity was measured by euglycaemic clamp (insulin infusion rate 1 mU kg-1 min-1) </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal rate (M-value) was considerably lower in patients (2.4+/-1.6 mg kg-1 min-1, 0.2-8.1) compared with healthy subjects (7.1+/-0.2 mg kg-1 min-1, p&lt;0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>M-value was strongly associated with WHR (r=-0.41, p&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>The patients with poorest insulin sensitivity had the highest level of total cholesterol (r=-0.41, p=0.02) and <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi> (r=-0.38, p=0.03) </plain></SENT>
<SENT sid="7" pm="."><plain>After 6 months of insulin treatment BMI was 30.3+/-4.2 kg/m2 (p&lt;0.05), mean weight increase was 2.7+/-0.8 kg </plain></SENT>
<SENT sid="8" pm="."><plain>M-value was substantially increased to 4.5+/-2.3 mg kg-1 min-1 (p&lt;0.001), the degree of improvement depended on basal insulin sensitivity (r=-0.55, p&lt;0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>HbA1c was reduced to 7.7+/-1.4% (p&lt;0.01), the correlation M-value with change of HbA1c (r=-0.59, p&lt;0.01) was shown </plain></SENT>
<SENT sid="10" pm="."><plain>Total cholesterol decreased from 6.3+/-1.1 to 5.4+/-1.1 mmol/l, <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi> from 4.1+/-1.1 to 3.4+/-1.0 mmol/l, <z:chebi fb="4" ids="17855">triglycerides</z:chebi> from 2.6+/-1.6 to 1.6+/-0.7 mmol/l (p&lt;0.001) </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, insulin treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients leads to decrease in <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> due to reduction in <z:chebi fb="105" ids="17234">glucose</z:chebi> toxicity and plasma atherogenicity despite <z:mp ids='MP_0005456'>weight gain</z:mp> </plain></SENT>
</text></document>